Glaxosmithkline Share News (GSK)

LONDON MARKET COMMENT: Stocks Called To Rebound With US Fed In Focus

Earnings, Trading Statements Calendar - Week Ahead

Biotechs seek cross-over to public markets

By Robert Sherwood NEW YORK, April 28 (IFR) - Early-stage biotech companies continue to find a favorable bid in both the private and public markets. Continuing the trend of late-stage crossover rounds, Adaptimmune Therapeutics and aTyr Pharma are looking to follow up recent private institut

LONDON MARKET CLOSE: FTSE 100 Reverses Three Days Of Gains

Earnings, Trading Statements Calendar - Week Ahead

GSK shingles vaccine shows benefits across all age groups

LONDON, April 28 (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmaker's development pipeline. In contrast to Merck's established Zostavax, currently

GlaxoSmithKline Gets Positive Data Late Stage Shingles Vaccine Trial

LONDON MARKET COMMENT: Stocks Lower As UK GDP Misses Expectations

BROKER RATINGS SUMMARY: Commerzbank And SocGen Say Buy IAG

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

World's first malaria vaccine moves closer to use in Africa

* Malaria kills more than 600,000 a year * Vaccine could be approved for use by October * Final findings show protection persists By Kate Kelland LONDON, April 24 (Reuters) - The world's first malaria vaccine, made by GlaxoSmithKline, could be approved by international reg